The UK's burgeoning landscape of consciousness-expanding substances is experiencing a significant shift, moving far outside the traditional attention on magic mushrooms and acid . Interest is currently focused on newer compounds, such as dimethyltryptamine, CBG a phytocannabinoid showing encouraging